Perspectives

Beyond binding: why we co-led BigHat Biosciences’ Series C 

Agents need more than intelligence. Why we invested in Databricks

The Downstream Effects of SpaceX, OpenAI, and Anthropic Soaking Up $3T in the Public Market, Who Is Netscape and Who Is Google in the AI Era, and the Impact of Private Credit Redemption Requests on PE and VC (Sandesh Patnam)

Robotics isn’t having its ChatGPT moment just yet

Formal verification just left the lab. Why we invested in Pramaana Labs.

CEO Series | Enveda: Building a 21st century generational pharma company.

CEO Series | DOSS: Turning operational complexity into competitive advantage

Why I take founders on a 3-mile hike before writing a check

Rearchitecting the Rigid ERP Core. Why we co-led Doss's $55M Series B

Goodbye VLAs. Why we led Rhoda's Series A

CEO Series | Ikigai

CEO Series | Kriya Therapeutics: Building Generational Biotech